SecBot SecBot

SVRA

Savara Inc
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001160308 Biotech & Drug Discovery
$4.47 −0.17 (−3.77%)
Nov 16 4:00 PM ET · prev $4.64
Market cap
$1.0B
Small cap
Consensus
Buy
93% Buy or better · 15 analysts
Median target
$10.50
+135% · range $9.00–16.00
1 year
+6.3%
from $4.20 · Nov 17
30 days
−3.6%
from $4.63
52-week range
$4.17–6.94
−36% from high · low Nov 18
Avg volume 20D
3.01M
Nov 11 spike 9.26M
Short interest
32.27M
≈15.7% of shares · +12.3%
Days to cover
12.9
at average volume
Insider net
−$2.2M
0 buyers · 1 seller · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Reddit crowd
50°
Neutral · 3 mentions this week
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score
Strongest🔒 Fresh report (last 24h), subscribers only

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

  • Jun 22 ▼ 1 insider sell $2.2M at $5.68
  • Oct 7 JP Morgan initiates
  • Oct 15 ▲ Short interest falls 34.0% to 28.74M

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider sold $2.2M.

  • InstitutionsBULLISH

    Q3 2026: 21 added (0 new), 6 trimmed or exited.

  • AnalystsBULLISH

    14 of 15 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.148 → −$0.169 over 90 days. 1 up, 4 down in 30 days.

  • Short sellersSTEADY

    Short interest +12.3% to 32.27M shares. 12.9 days to cover, ≈15.7% of shares.

  • TrendDOWNTREND

    9% below its 50-day average.

  • SocialQUIET

    Crowd 50° (neutral) this week from 3 mentions: 0 bullish, 0 bearish. No setup is alerting.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGADD700,908$3.6M
FMR LLCDOUBLED505,921$2.6M
BANK OF MONTREAL /CAN/DOUBLED265,240$1.4M
Jump Financial, LLCDOUBLED139,578$720.2K
Rafferty Asset Management, LLCADD137,917$711.7K
Magnetar Financial LLCDOUBLED78,746$406.3K
VANGUARD ASSET MANAGEMENT, LtdADD74,175$382.7K
Squarepoint Ops LLCDOUBLED73,071$377.0K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

15 analysts
Buy 93% rate it Buy or better
Strong Buy5Buy9Hold1Sell0Strong Sell0
12-month targets · 9 analysts

Price is below the lowest target. Median implies +135%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Oct 7, 2026JP Morgan
INITIATE
INITIATEOverweight
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

Insider ledger

Form 4
$0
bought · 0 insiders
$2.2M
sold · 1 insider
DateInsiderTypeValue
Sep 24, 2026
Parker Braden C.
Chief Commercial Officer
Sep 24, 2026
TAX W/H$148.7K
Jul 15, 2026
Lutz Robert Matthew
Chief Fin. & Operating Officer
Jul 15, 2026
AWARD35,000 sh
Jul 15, 2026
Lutz Robert Matthew
Chief Fin. & Operating Officer
Jul 15, 2026
AWARD70,000 sh
Jun 22, 2026
Lowrance David L
Chief Financial Officer
Jun 22, 2026
EXERCISE$119.3K
Jun 22, 2026
Lowrance David L
Chief Financial Officer
Jun 22, 2026
TAX W/H$119.3K
Jun 22, 2026
Lowrance David L
Chief Financial Officer
Jun 22, 2026
SELL$2.2M
Jun 22, 2026
Lowrance David L
Chief Financial Officer
Jun 22, 2026
EXERCISE$159.1K
Jun 22, 2026
Lowrance David L
Chief Financial Officer
Jun 22, 2026
TAX W/H$159.1K

Earnings setup

Estimates
−$0.17
EPS estimate, this quarter
−14%
estimate change, 90 days
1↑ 4↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.17-$0.23–-$0.15-8.3%$1.3M
Next Q-$0.15-$0.20–-$0.12+3.2%$7.6M
Current FY-$0.65-$0.77–-$0.59+0.1%$1.3M
Next FY-$0.37-$0.56–-$0.06-0.7%$78.5M

Washington

Corporate Lobbying

5 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
32,273,605
shares short
+12.3%
vs prior settlement
12.9
days to cover
≈15.7%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 5, 2026 Earnings calendar
SVRA Q3 2026 Earnings After Market Close · 2026-11-05
Sep 30, 2026 Inst.
UBS Group AG · ADD
700,908 shares ($3.6M)
Sep 30, 2026 Inst.
FMR LLC · DOUBLED
505,921 shares ($2.6M)
Sep 24, 2026 Insider
Parker Braden C. surrendered for taxes 29,323 shares
Chief Commercial Officer @ $5.07 ($148.7K)
Aug 9, 2026 SEC
Five institutional investors, including Citigroup and Russell Investments Group, significantly increased their…
INST-CLUSTER · Impact 5/10
Jul 15, 2026 Insider
Lutz Robert Matthew was granted 35,000 shares
Chief Fin. & Operating Officer
Jul 15, 2026 Insider
Lutz Robert Matthew was granted 70,000 shares
Chief Fin. & Operating Officer
Reddit Mentions per day, 14 days
Crowd this week 50° Neutral 0 bullish · 0 bearish
Mentions, 7 days 3 1 in posts · 2 in comments
Recent posts
Recent comments
All social signals and their track records

SecBot reports

4 filings · 1 bullish · 0 bearish · 1 mixed · 2 neutral
All SVRA filing & press-release reports (4)